Ypsomed and Smartpatient Partner to Connect Injection Devices with Digital Support

Ypsomed and smartpatient have partnered to integrate smart injection devices with digital patient support, enhancing the patient experience and providing pharmaceutical companies with a scalable solution for connected therapies.

Ypsomed, a leading developer and manufacturer of self-injection systems for the self-administration of liquid medication, has joined forces with smartpatient, the leading provider of direct-to-patient solutions for the pharmaceutical industry. Through their collaboration, the companies aim to transform the way patients manage their treatments by connecting injection data with broader digital support.

The partnership introduces SmartPilot, a solution that links Ypsomed’s YpsoMate autoinjector to MyTherapy, a widely used medication management app. This integration allows for the capture and digitalization of injection-related information, which can then be integrated into a patient's broader digital health journey. Patients receive therapy-specific education, medication reminders, and adherence support, all of which are designed to enhance their overall treatment experience.

The integration of SmartPilot into the MyTherapy ecosystem is designed to establish a reusable foundation that can be adapted to the requirements of different pharmaceutical products and patient populations. The connected device, companion experience, and patient support program work together as one connected patient journey, from injection to everyday therapy management.

Ypsomed, with its experience of more than 40 years in providing tailored self-care solutions, and smartpatient, with its extensive experience in developing direct-to-patient solutions, are well-positioned to deliver this innovative partnership. More than 2,000 employees worldwide are committed to making self-care simpler and easier, ensuring that the partnership can be scaled to meet the needs of a wide range of patients.

The first implementation of the integration is currently under development, with further details to be announced as the collaboration progresses. This partnership marks a significant step in the evolution of digital health solutions, offering pharmaceutical companies a comprehensive approach to connected therapies that extends beyond the injection itself.

By combining Ypsomed's expertise in self-injection systems with smartpatient's digital capabilities, the partnership aims to create a seamless and supportive patient experience that can be tailored to the specific needs of different treatments and patient populations.